NCT00869024View on ClinicalTrials.gov

Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 10, 2011

Primary Completion Date

March 29, 2016

Study Completion Date

March 29, 2016

Conditions
Heart Failure
Interventions
BIOLOGICAL

Intramyocardial Delivery of Bone Marrow Derived Mononuclear Cells

Ten separate injections will be delivered into the LV free wall (20 X 106 cells / 400 micro lit).

Trial Locations (1)

55455

University Of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT00869024 - Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement | Biotech Hunter | Biotech Hunter